Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

F Passiglia; S Pilotto; F Facchinetti; L Bertolaccini; M Del Re; R Ferrara; T Franchina; U Malapelle; J Menis; A Passaro; S Ramella; G Rossi; R Trisolini; S Novello

doi:10.1016/j.critrevonc.2019.102858

Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

F Passiglia, S Pilotto, F Facchinetti, L Bertolaccini, M Del Re, R Ferrara, T Franchina, U Malapelle, J Menis, A Passaro, S Ramella, G Rossi, R Trisolini, S Novello

Research output: Contribution to journal › Review article › peer-review

Abstract

The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.

Original language	English
Article number	102858
Pages (from-to)	1-11
Number of pages	11
Journal	Critical Reviews in Oncology/Hematology
Volume	146
DOIs	https://doi.org/10.1016/j.critrevonc.2019.102858
Publication status	E-pub ahead of print - Dec 28 2019

Access to Document

10.1016/j.critrevonc.2019.102858

Cite this

Passiglia, F., Pilotto, S., Facchinetti, F., Bertolaccini, L., Del Re, M., Ferrara, R., Franchina, T., Malapelle, U., Menis, J., Passaro, A., Ramella, S., Rossi, G., Trisolini, R., & Novello, S. (2019). Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. Critical Reviews in Oncology/Hematology, 146, 1-11. [102858]. https://doi.org/10.1016/j.critrevonc.2019.102858

Treatment of advanced non-small-cell lung cancer : The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. / Passiglia, F; Pilotto, S; Facchinetti, F ; Bertolaccini, L; Del Re, M; Ferrara, R; Franchina, T; Malapelle, U; Menis, J ; Passaro, A; Ramella, S; Rossi, G; Trisolini, R; Novello, S.

In: Critical Reviews in Oncology/Hematology, Vol. 146, 102858, 28.12.2019, p. 1-11.

Research output: Contribution to journal › Review article › peer-review

Passiglia, F, Pilotto, S, Facchinetti, F , Bertolaccini, L, Del Re, M, Ferrara, R, Franchina, T, Malapelle, U, Menis, J , Passaro, A, Ramella, S, Rossi, G, Trisolini, R & Novello, S 2019, 'Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines', Critical Reviews in Oncology/Hematology, vol. 146, 102858, pp. 1-11. https://doi.org/10.1016/j.critrevonc.2019.102858

Passiglia, F ; Pilotto, S ; Facchinetti, F ; Bertolaccini, L ; Del Re, M ; Ferrara, R ; Franchina, T ; Malapelle, U ; Menis, J ; Passaro, A ; Ramella, S ; Rossi, G ; Trisolini, R ; Novello, S. / Treatment of advanced non-small-cell lung cancer : The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. In: Critical Reviews in Oncology/Hematology. 2019 ; Vol. 146. pp. 1-11.

@article{867eca79d12d4accb09f14a1e56a09b7,

title = "Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines",

abstract = "The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.",

author = "F Passiglia and S Pilotto and F Facchinetti and L Bertolaccini and {Del Re}, M and R Ferrara and T Franchina and U Malapelle and J Menis and A Passaro and S Ramella and G Rossi and R Trisolini and S Novello",

year = "2019",

month = dec,

day = "28",

doi = "10.1016/j.critrevonc.2019.102858",

language = "English",

volume = "146",

pages = "1--11",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Treatment of advanced non-small-cell lung cancer

T2 - The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

AU - Passiglia, F

AU - Pilotto, S

AU - Facchinetti, F

AU - Bertolaccini, L

AU - Del Re, M

AU - Ferrara, R

AU - Franchina, T

AU - Malapelle, U

AU - Menis, J

AU - Passaro, A

AU - Ramella, S

AU - Rossi, G

AU - Trisolini, R

AU - Novello, S

PY - 2019/12/28

Y1 - 2019/12/28

N2 - The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.

AB - The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.

U2 - 10.1016/j.critrevonc.2019.102858

DO - 10.1016/j.critrevonc.2019.102858

M3 - Review article

C2 - 31918343

VL - 146

SP - 1

EP - 11

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

M1 - 102858

ER -

Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

Abstract

Access to Document

Fingerprint

Cite this